NCT05776134 2026-04-08Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene AutoleucelGilead SciencesAvailable
NCT06144606 2026-03-31Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)H. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting60 enrolled